Two Sigma Securities’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.9K | Buy |
+16,064
| New | +$16.9K | ﹤0.01% | 1238 |
|
2025
Q1 | – | Sell |
-19,395
| Closed | -$31.5K | – | 1491 |
|
2024
Q4 | $31.5K | Sell |
19,395
-10,175
| -34% | -$16.5K | ﹤0.01% | 1055 |
|
2024
Q3 | $59.4K | Buy |
+29,570
| New | +$59.4K | ﹤0.01% | 1119 |
|
2023
Q1 | – | Sell |
-2,699
| Closed | -$16.5K | – | 1393 |
|
2022
Q4 | $16.5K | Buy |
2,699
+1,242
| +85% | +$7.61K | ﹤0.01% | 1085 |
|
2022
Q3 | $11K | Buy |
+1,457
| New | +$11K | ﹤0.01% | 1174 |
|
2022
Q1 | – | Sell |
-1,781
| Closed | -$23K | – | 1148 |
|
2021
Q4 | $23K | Buy |
+1,781
| New | +$23K | ﹤0.01% | 891 |
|
2021
Q3 | – | Sell |
-1,018
| Closed | -$23K | – | 897 |
|
2021
Q2 | $23K | Sell |
1,018
-4,387
| -81% | -$99.1K | ﹤0.01% | 651 |
|
2021
Q1 | $134K | Buy |
+5,405
| New | +$134K | 0.01% | 450 |
|
2020
Q3 | – | Sell |
-1,001
| Closed | -$20K | – | 555 |
|
2020
Q2 | $20K | Buy |
+1,001
| New | +$20K | ﹤0.01% | 513 |
|
2019
Q3 | – | Sell |
-1,301
| Closed | -$37K | – | 779 |
|
2019
Q2 | $37K | Buy |
+1,301
| New | +$37K | ﹤0.01% | 720 |
|
2018
Q4 | – | Sell |
-86
| Closed | -$17K | – | 1217 |
|
2018
Q3 | $17K | Buy |
+86
| New | +$17K | ﹤0.01% | 1087 |
|